We are live on ! Find out more
OCEA

Ocean Biomedical, Inc. Common Stock

Delisted

OCEA was delisted on the 23rd of April, 2025.

35 hedge funds and large institutions have $103M invested in Ocean Biomedical, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

10% more capital invested

Capital invested by funds: $93.4M → $103M (+$9.55M)

3% more funds holding

Funds holding: 3435 (+1)

Holders
35
Holders Change
+1
Holders Change %
+2.94%
% of All Funds
0.59%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
3
Closed
3
Calls
$143K
Puts
Net Calls
+$143K
Net Calls Change
+$1K
Name Holding Trade Value Shares
Change
Change in
Stake
AI
26
Arena Investors
New York
$560K
Walleye Capital
27
Walleye Capital
New York
$541K -$2.02K -200 -0.4%
HF
28
HRT Financial
New York
$497K
DWM
29
Dakota Wealth Management
Florida
$435K
AA
30
AQR Arbitrage
Connecticut
$420K
CC
31
Centiva Capital
New York
$377K +$30.2K +2,985 +9%
Goldman Sachs
32
Goldman Sachs
New York
$364K
Walleye Trading
33
Walleye Trading
New York
$364K
EFI
34
EHP Funds Inc
Canada
$253K
Blackstone Inc
35
Blackstone Inc
New York
$147K
BCM
36
Beryl Capital Management
California
-$6.79M -673,674 Closed
SCC
37
Spring Creek Capital
Kansas
-$1.37M -135,500 Closed
WA
38
Whitebox Advisors
Minnesota
-$1.04M -102,800 Closed

OCEA Hedge Fund Activity: Q2 2022 in Review

35 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q2 2022, worth a combined $103M — up 10% from $93.4M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new OCEA positions and 3 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.

The largest buyer was First Trust Capital Management, opening a new position worth an estimated $5.75M. The largest seller was Beryl Capital Management, exiting entirely with an estimated $6.79M sold.

  • 35 institutional investors held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q2 2022, up from 34 in Q1 2022.
  • Funds reported $103M of Ocean Biomedical, Inc. Common Stock stock for Q2 2022, up 10% quarter-over-quarter.
  • 4 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q2 2022 and 3 closed out, a net change of +1 holder.
  • The largest Ocean Biomedical, Inc. Common Stock buyer in Q2 2022 was First Trust Capital Management, an estimated $5.75M added.
  • The largest Ocean Biomedical, Inc. Common Stock seller in Q2 2022 was Beryl Capital Management, an estimated $6.79M sold.

Based on aggregated 13F filings for Q2 2022.